Quantum computing's potential for drug discovery: Early stage industry dynamics
| Autor: | Maximillian Zinner, Linn Bieske, Leonard Fehring, Florian Dahlhausen, Philip Boehme, Jan P. Ehlers |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Pharmacology Drug Industry Drug discovery business.industry Computer science Stakeholder Data science Computing Methodologies Field (computer science) Quantum technology Industry dynamics 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Drug development 030220 oncology & carcinogenesis Drug Discovery Quantum Theory business Pharmaceutical industry Quantum computer |
| Zdroj: | Drug discovery today. 26(7) |
| ISSN: | 1878-5832 |
| Popis: | Quantum computing (QC) is expected to revolutionize drug research by performing tasks classical supercomputers are not capable of. However, practically useful quantum computation is not yet a reality, and thus it is still unclear when and whether QC will be capable of solving real-world issues in drug discovery. By identifying the QC-related activities of pharmaceutical companies, startups, and academia in the field of drug discovery and development, we show that QC has gained traction across all of these stakeholder groups, that there is focus on developing utilities related to lead optimization and compound screening, and that there is a need for collaboration in the highly dynamic QC ecosystem. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect